NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis

Abstract

Background At the beginning of tumorigenesis, newly born cancer cells must successfully avoid attack by the immune system. Although most abnormal cells are efficiently identified and destroyed by the immune system, particularly by NK cells, the molecular mechanisms by which newly born cancer cells evade NK cell surveillance are not fully understood. Methods NK cell resistance of highly tumorigenic population of human prostate cancer (PCa) cells were confirmed by xenograft in SCID mice with or without NK cell neutralization. The mechanisms by which the tumorigenic PCa cells evaded NK cell attack were investigated by RNAseq, ChIPseq, generation of several transformants and xenograft in SCID mice. Results Here, we show that PCa cells have a strengthened ability to escape NK cell attack due to NANOG, a pluripotent-related transcription factor, mediating the repression of ICAM1, a cell adhesion molecule, during tumorigenesis. Mechanistically, NANOG directly binds to the region upstream of ICAM1. As the binding between NANOG and the upstream ICAM1 region increases, p300 binding to this region is diminished, resulting in decreased ICAM1 expression. High NANOG expression confers PCa cells the ability to resist NK cell attack via the repression of ICAM1. Consistent with these results, low ICAM1 expression is significantly correlated with a high recurrence rate in patients with PCa. Conclusions Our findings indicate that repression of ICAM1 is a critical mechanism by which cancer cells evade attack from NK cells during tumorigenesis. These results suggest a pivotal role of NANOG in establishing a gene expression profile for escaping the immune system.

EPS364, a Novel Deep-Sea Bacterial Exopolysaccharide, Inhibits Liver Cancer Cell Growth and Adhesion

“…Compared to nontreated cells, the expressions of cell adhesion molecules and ECM (extracellular matrix)-receptor interaction molecules were significantly downregulated in EPS364-treated cells ( Figure 6 A). The expressions of cell adhesion molecules, especially ALCAM (activated leukocyte cell adhesion molecule) and ICAM1 (intercellular adhesion molecule 1), which have been reported to play vital roles in cancer cell adhesion [ 26 , 27 , 28 , 29 ], were remarkably downregulated ( Figure 6 B). Downregulating the expression of adhesion molecules indicated that the cell adhesion capability was reduced.…”

Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis

“…Accordingly, tumor cells (not just PCa cells) express several surface markers or immunocyte regulatory factors to escape NK cells. With PCa cells, the stem cell marker, nanoG, was proven to help PCa cells to escape destruction by NK cells through downregulating intercellular adhesion molecule 1 (iCAMP1) [59]. Additionally, nanoG also triggers various cancer stem cell markers and chemokine receptors, such as C-X-C motif receptor 4 (CXCR4), CD133, aldehyde dehydrogenase 1 (ALDH1), and insulin-like growth factor (IGF)-binding protein 1 (IGFBP1) [60].…”

A simple method using CRISPR-Cas9 to knock-out genes in murine cancerous cell lines

“…Next, we examined if the shape of the end of the DNA coding the selection marker was critical for generating KO clones using high blasticidin S concentration. Although introduction of an un-cut plasmid with a selection marker is known to establish transgenic clones by random integration of the plasmid into the genome 11 , the un-cut plasmid with a selection marker did not allow cells to form colonies under the high antibiotic dose (Fig. 3 A).…”